Beth Israel Deaconess targets new treatment for vision loss
Table of Contents
Add a header to begin generating the table of contents
“Researchers at Beth Israel Deaconess Medical Center believe they have discovered a new way to treat one of the leading causes of vision loss, an approach that favors eye drops in place of a commonly used procedure that involves eye injections with a needle.
Approximately 14 million people in the U.S. develop the targeted condition in the retina, called aged macular degeneration. The condition is also prevalent in premature infants. Current treatments involve monthly injections of large molecules directly into the eyeball.”
To read more of Jessica Bartlett’s article please visit: Boston Business Journal
